Læknablaðið - nov. 2020, Side 28

522 L ÆK N A BL AÐIÐ 2020/106
Heimildir
1. Roth G, Huffman M, Moran A, et al. Global and regional patterns in cardiovascular morta-
lity from 1900 to 2013. Circulation 2015; 132: 1667-78.
2. St-Onge M, Zuraikat F. Reciprocal Roles of Sleep and Diet in Cardiovascular Health: a
Review of Recent Evicence and a Potential Mechanism. Curr Atheroscler Rep 2019; 21: 11.
3. Grandner M, Alfonso-Miller P, Fernandez-mendoza J, et al. Sleep: Important Considerations
for the Prevention of Cardiovascular Disease. Curr Opin Cardiol 2016; 31: 551-65.
4. Bin Y, Marshall N, Glozier N. Secular trends in adult sleep duration: a systematic review.
Sleep Med Rev 2012; 16: 223-30.
5. Grandner M. Sleep, Health and Society. Sleep Med Clin 2017; 12: 1-22.
6. Rangaraj V, Knutson K. Association between sleep deficiency and cardiometabolic disease:
implications for health disparities. Sleep Med 2016; 18: 19-35.
7. Chattu V, Manzar D, Kumary S, et al. The Global Problem of Insufficient Sleep and Its
Serious Public Health Implications. Healthcare (Basel) 2019; 7: 1.
8. Cappuccio F, Miller M. Sleep and Cardio-Metabolic Disease. Curr Cardiol Rep 2017; 11: 110.
9. Ge L, Guyatt G, Tian J, et al. Insomnia and risk of mortality from all-cause, cardiovascular
disease and cancer: systematic review and meta-analysis of prospective cohort studies. Sleep
Med Rev 2019; 48: 101215.
10. Yong C, Choi J. Association of sleep disturbance with risk of cardiovascular disease and
all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-
HEALS. Cardiovasc Diabetol 2020; 2019: 61.
11. Ding C, Lim L, Xu L, et al. Sleep and Obesity. J Obes Metab Syndr 2018; 27: 4-24.
12. Fernandez-Mendoza J. The insomnia with short sleep duration phenotype: an update on it’s
importance for health and prevention. Curr Opin Psychiatry 2017; 30: 56-63.
13. Hirshkowitz M, Whiton K, Alpert S, et al. National Sleep Foundation´s sleep time duration
recommendations: Methodology and results summary. Sleep Health 2015; 1: 233-43.
14. Silvani A, Dampney R. Central control of cardiovascular functioning during sleep. Am J
Physiol Heart Circ Physiol 2013; 305; H1683-H1692.
15. Fink A, Bronas U, Calik C. Autonomic regulation during sleep and wakefulness: a review
with implications for defining the pathophysiology of neurological disorders. Clin Auton
Res 2018; 28: 509-18.
16. Tobaldini E, Costantino G, Monica S, et at. Sleep, sleep deprivation, autonomic nervous
system and cardiovascular diseases. Neurosci Biobehav Rev 2017; 74: 321-9
17. Gronfier C, Brandenberger G. Ultradian rhythms in pituitary and adrenal hormones: their
relation to sleep. Sleep Med Rev 1998; 2: 17-29.
18. Ooms S, Overeem S, Besse K, et al. Effect of 1 night of total sleep deprivation on cerebro-
spinal fluid b-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA
Neurol 2014; 71: 971-7.
19. Shi L, Chen S, Ma M, et al. Sleep disturbances increase the risk of dementia: A systematic
review and meta-analysis. Sleep Med Rev 2018; 40: 4.
20. Shrivastava D, Jung S, Saadat M, et al. How to interpret the results of a sleep study. J
Community Hosp Intern Med Perspect 2014: 4: 24983.
21. Bhaskar S, Hemavathy D, Shankar P. Prevalence of chronic insomnia in adult patients and
its correlation with medical comorbidities. J Family Med Primary Care 2016; 5: 780-4.
22. Vaughn B, D‘Cruz O. Cardinal Manifestations of Sleep Disorders. Í: Kryger M, Roth T,
Dement W, ritstj. Principles and Practice of Sleep Medicine, 6. útg. Elsevier, Philadelphia
2017: 576-86.
23. Altman N, Schopfer E, Jackson N, et al. Sleep Duration versus Sleep Insufficiency as
Predictors of Cardiometabolic Health Outcomes. Sleep Med 2012; 13: 1261-70.
24. Aziz M, Ali S, Das S, et al. Association of Subjective and Objective Sleep Duration as well as
Sleep Quality with Non-Invasive Markers of Sub-Clinical Cardiovascular Disease (CVD): A
Systematic Review. J Atheroscler Thromb 2017; 24: 208-26.
25. Lao X, Liu X, Deng H, et al. Sleep Quality, Sleep Duration, and the risk of Coronary Heart
Disease: A Prospective Cohort Study With 60,586 Adults. J Clin Sleep Med 2018; 14: 109-17.
26. Kwok C, Kontopantelis E, Kuligowski G, et al. Self-Reported Sleep Duration and Quality
and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis. J Am Heart
Assoc 2018; 7: e008552.
27. Jike M, Itani O, Watanabe N, et al. Long sleep duration and health outcomes: A systematic
review, meta-analysis and meta-regression. Sleep Med Rev 2018; 39: 25-36.
28. Javaheri S, Redline S. Insomnia and Risk of Cardiovascular Disease. Chest 2017; 152: 435-44.
29. Itani O, Jike M, Watanabe N. Short sleep duration and health outcomes: a systematic review,
meta-analysis and meta-regression. Sleep Med 2017; 32: 246-56.
30. Khan M, Aouad R. The Effects of Insomnia and Sleep Loss on Cadiovascular Disease. Sleep
Med Clin 2017; 12: 167-77.
31. Covassin N, Singh P. Sleep Duration and Cardiovascular Disease Reisk: Epidemiologic and
Experimental Evidence. Sleep Med Clin 2016; 11: 81-89.
32. Wang D, Li W, Cui X, et al. Sleep duration and risk of coronary heart disease: a systematic
review and meta-analysis of prospective cohort studies. Int J Cardiol 2016; 219: 231-9.
33. Ibanez V, Silva J, Cauli O. A survey on sleep questionnaires and diaries. Sleep Med 2018; 42:
90-6.
34. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing
for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice
guideline. J Clin Sleep Med 2017; 13: 479-504.
35. Hilmisson H, Berman S, Magnusdottir S. Sleep apnea diagnosis in children using software-
generated apnea-hypopnea index (AHI) derived from data recorded with a single photop-
lethysmogram sensor (PPG). : Results from the Childhood Adenotonsillectomy Study
(CHAT) based on cardiopulmonary coupling analysis. Sleep Breath 2020, Mar 28.
36. Vgontzas A, Fernandez-Mendoza J, Liao D, et al. Insomnia with objective short sleep dura-
tion: the most biologically severe phenotype of the disorder. Sleep Med Rev 2013; 17: 214-52.
37. Marques D, Gomes A, Clemente V, et al. Hyperarousal and failure to inhibit wakefulness in
primary insomnia “Birds of a feather”? Sleep Ciol Rhythms 2016; 13: 219-28.
38. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the Evaluation and
Management of Chronic Insomnia in Adults. J Clin Sleep Med 2008; 4: 487-504.
39. Kendreska T, Mollayeva T, Gershorn AS, et al. Untreated obstructive sleep apnea and the
risk for serious long-term adverse outcomes: a systematic review. Sleep Med Rev 2014; 18:
49-59.
40. Dominguez F, Fuster V, Gernandez-Avlira J, et al. Association of Sleep Duration and quality
With Subclinical Atherosclerosis. J Am Coll Cardiol 2019; 44-134 :73.
41. Seneratna C, Perret JL, Lodge CJ, et al. Prevalence of Obstructive sleep apnea in the general
population: a systematic review. Sleep Med Rev 2017; 34: 70-81.
42 Sweetman A, Lack L, Bastien C. Co-Morbid Insomnia and Sleep Apnea (COMISA):
Prevalence, Consequences, Methodological Considerations, and Recent Randomized
Controlled Trials. Brain Sci 2019; 9: 371.
43. Hilmisson H, Sveinsdottir E, Lange N, et al. Insomnia in Primary Care: Prospective study
focusing on prevalence of undiagnosed co-morbid Sleep Disordered Breathing. Eur J Intern
Med 2019; 63: 19-26.
44. Krakow B, McIver N, Ulibarri V, et al. Prospective Randomized Controlled Trial on the
Efficacy of Continuous Positive Airway Pressure and Adaptive Servo-Ventilation in the
Treatment of Chronic Complex Insomnia. Lancet 2019; 13: P57-73.
45. Jafari B. Sleep Architecture and Blood Pressure. Sleep Med Clin 2017; 12: 161-6.
46. Khayat R, Pleister A. Consequences of obstructive sleep apnea. Sleep Med Clin 2016; 11: 279-
86.
47. Makarem N, Shechter A, Carnethon M, et al. Sleep Duration and Blood Pressure: Recent
Advances and Future Directions. Curr Hypertens Rep 2019; 21: 33.
48. Jarrin D, Alvaro P, Bouchard M, et al. Insomnia and hypertension: A systematic review.
Sleep Med Rev 2018; 41: 3-38.
49. Thomas S, Calhoun D. Sleep, insomnia and hypertension: current findings and future direc-
tions. J Am Soc Hypertens 2017; 11: 122-9.
50. Yang H, Haack M, Gautam S, et al. Repetitive exposure to shortened sleep leads to blunted
sleep-associated blood pressure dipping. J Hypertens 2017; 35: 1187-94.
51. Vgontzas A, Liao D, Bixler E, et al. Insomnia with objective short sleep duration is associated
with a high risk for hypertension. Sleep 2009; 32: 491-7.
52. Jarrin D, Ivers H, Lamy M, et al. Cardiovascular autonomic dysfunction in insomnia patients
with objective short sleep duration. J Sleep Res 2018; 27: e12663.
53. Haack M, Serrador J, Cohen D, et al. Increasing sleep duration to lower beat-to-beat blood
pressure – a pilot study. J Sleep Res 2013; 22: 295-304.
54. Magnusdottir S, Hilmisson H, Thomas RJ. Cardiopulmonary coupling derived sleep quality
is associated with improvements in blood pressure in patients with obstructive sleep apnea
at high cardiovascular risk. J Hypertens 2020; 38: 2287-94.
55. Koren D, Dumin M, Gozal D. Role of sleep quality in the metabolic syndrome. Diabetes
Metab Syndr Obes 2016; 9: 281-310.
56. Sadamatsu M, Kato N, Lida H, et al. The 24-hour rhythms in plasma growth hormone,
prolactin and thyroid stimulating hormone: effect of sleep deprivation. J Neuroendocrinol
1995; 7: 597-606.
57. Dashti H, Follis J, Smith C, et al. Habitual sleep duration is associated with BMI and macron-
utrient intake and may be modified by CLOCK genetic variants. Am J Clin Nutr 2015; 101:
135-43.
58. Gonzalez-Ortiz M, Martinez-Abundis E, Balcazar-Munoz B, et al. Effect of sleep deprivation
on insulin sensitivity and cortisol concentrartion in healthy subjects. Diabetes Nutr Metab
2000; 13: 80-3.
59. Achari A, Jain S. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial
Dysfunction. Int J Mol Sci 2017; 18: 1321.
60. Kim DH, Kim C, Ding EL, et al. Adiponectin levels and the risk of hypertension: a systematic
review and meta-analysis. Hypertension 2013; 62: 27-32.
61. Ohashi K, Ouchi N, Matsuzawa Y. Adiponectin and Hypertension. Am J Hypertens 2011; 24:
263-9.
62. Lu M, Fang F, Wang Z, et al. Association between serum/plasma levels of adiponectin and
obstructive sleep apnea hypopnea syndrome: meta-analysis. Lipids Health Dis 2019; 18: 30.
63. Tobaldini E, Fiorelli EM, Solbiati M, et al. Short sleep duration and cardiometabolic risk:
from pathophysiology to clinical evidence. Nat Rev Cardiol 2019; 16: 213-24.
64. St-Onge M, Grandner M, Brown D, et al. Sleep duration and quality: impact on lifestyle
behaviors and cardiometabolic health: a scientific statement from the American Heart
Association. Circulation 2016; 134: e367-e386.
65. Fioranelli M, Bottaccioli A, Bottaccioli F, et al. Stress and Inflammation in Coronary Artery
Disease: A Review Psychoneuroendocrineimmunology-Based. Front Immunol 2018; 9: 2031.
66. Irwin M, Olmstead R, Carroll J. Sleep Disturbance, Sleep Duration and Inflammation:
A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep
Deprivation. Biol Psychiatry 2016; 80: 40-52.
67. Yin J, Jin X, Shan Z, et al. Relationship of Sleep Duration With All-Cause Mortality and
Cardiovascular Events: A systematic Review and Dose-Response Meta-Analysis of
Prospective Cohort Studies. J Am Heart Assoc 2017; 6: e005947.
68. Krittanawong C, Tunhasiriwet A, Wang Z, et al. Association between short and long sleep
durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J
Acute Cardiovasc Care 2019; 8: 762-70.
69. Fernandez-Mendoza J, He F, Vgontzas A, et al. Interplay of Objective Sleep Duration and
Cardiovascular and Cerebrovascular Disease on Cause-Specific Mortality. J Am Heart Assoc
2019; 8: e013043.
70. Ning Y, Zhang T, Wen W, et al. Effects of coninous positive airway pressure on cardiovascul-
ar biomarkers in patients with obstructive sleep apnea: a meta-analysis of randomized
controlled trials. Sleep Breath 2018; 23: 77-86.
Allur heimildalistinn (1-96) er birtur með greininni á heimasíðu Læknablaðsins.
Y F I R L I T